INTRODUCTION {#sec1}
============

Magnetotactic bacteria (MTB) are a group of diverse microorganisms that align along magnetic fields via their intracellular chains of magnetic crystals ([@B1], [@B2]). Each magnetic crystal consists of either magnetite (Fe~3~O~4~) or greigite (Fe~3~S~4~) and is synthesized within a complex organelle called a magnetosome ([@B3]). The first cultured MTB were microaerophilic members of the Alphaproteobacteria, which form cubooctahedral-shaped magnetite crystals and have served as model organisms for understanding magnetosome formation ([@B4][@B5][@B7]). Early studies on Magnetospirillum spp. revealed a lipid-bilayer membrane, with a unique suite of proteins, surrounding each magnetite crystal ([@B8][@B9][@B10]). The development of genetic tools in Magnetospirillum magneticum AMB-1 and Magnetospirillum gryphiswaldense MSR-1 revealed a conserved [ma]{.ul}gnetosome gene [i]{.ul}sland (MAI) that contains the factors necessary and sufficient for the formation of the magnetosome membrane, magnetite biomineralization within the lumen of the magnetosome, and alignment of the magnetosomes in a chain along the length of the cell ([@B3], [@B11]). These molecular advances, along with the magnetic properties of magnetosomes, have made MTB ideal models for the study of compartmentalization and biomineralization in bacteria as well as a target for the development of biomedical and industrial applications.

Improvements in isolation techniques and sequencing have revealed that MTB are ubiquitous in many aquatic environments. On the basis of phylogeny and magnetosome morphology, MTB can be categorized into two subgroups. The first subgroup includes members of the Alphaproteobacteria and Gammaproteobacteria, such as Magnetospirillum spp., that synthesize cubooctahedral, elongated octahedral, or elongated prisms of magnetite ([@B12]). The second subgroup comprises MTB from more deep-branching lineages, including members of the Deltaproteobacteria class and the Nitrospirae and Omnitrophica phyla, which synthesize elongated bullet-/tooth-shaped magnetite and/or greigite crystals ([@B13], [@B14]). While all MTB sequenced to date have their putative magnetosome genes arranged in distinct regions of their genomes ([@B3], [@B15][@B16][@B17]), many of the genes essential for magnetosome biogenesis in Magnetospirillum spp. are missing from the genomes of deep-branching MTB ([@B14]). Likewise, a conserved set of *mad* ([m]{.ul}agnetosome-[a]{.ul}ssociated *[D]{.ul}eltaproteobacteria*) genes are only found in deep-branching MTB ([@B14], [@B18][@B19][@B20]). This suggests a genetic diversity underpinning the control of magnetosome morphology and physiology in nonmodel MTB that is distinct from that of the well-characterized Magnetospirillum spp.

Desulfovibrio magneticus RS-1, one of the few cultured MTB outside the Alphaproteobacteria, is an anaerobic sulfate-reducing member of the Deltaproteobacteria that forms irregular bullet-shaped crystals of magnetite ([@B21], [@B22]). As with the Magnetospirillum spp., the magnetosome genes of D. magneticus are located within a MAI and include homologs to some *mam* genes as well as *mad* genes ([@B14], [@B18], [@B23]). Recently, we used a forward genetic screen combining random chemical and UV mutagenesis with whole-genome resequencing to identify mutations that resulted in nonmagnetic phenotypes. These included many mutants that had the entire MAI deleted (ΔMAI) as well as mutants with point mutations, frameshift mutations, and transposon insertions in 10 *mam* and *mad* genes of the D. magneticus MAI that resulted in nonmagnetic phenotypes ([@B20]). However, this screen relied on a strict selection scheme for nonmagnetic mutants. As such, we likely missed magnetosome genes that are important for regulating the shape, size, and arrangement of magnetosomes. To elucidate the degree of conservation between *mam* genes and determine the function of the proteins encoded by *mad* genes in D. magneticus, a reverse genetic method for targeted mutagenesis is necessary.

D. magneticus and other Desulfovibrio spp. have gained much attention for their importance in the global cycling of numerous elements, in biocorrosion, and in the bioremediation of toxic metal ions ([@B24], [@B25]). The development of genetic tools, such as expression vectors, transposons, and targeted genome-editing systems, has enabled a more detailed examination of the important activities of a few Desulfovibrio spp. ([@B26], [@B27]). Targeted mutagenesis using a one-step double recombination method was first achieved in Desulfovibrio fructosivorans and, more recently, in Desulfovibrio gigas and Desulfovibrio desulfuricans ND132 ([@B28][@B29][@B30]). With this method, plasmids that are electroporated into the cell are thought to be rapidly linearized by endogenous restriction modification systems ([@B30][@B31][@B32]). The linearized plasmid DNA, carrying a selectable marker flanked by upstream and downstream regions of homology to a target gene, can then undergo double recombination into the chromosome in one step ([Fig. 1A](#F1){ref-type="fig"}). This efficient one-step method, which is dependent on electroporation of the plasmid ([@B28][@B29][@B30]), is unlikely to be applicable for D. magneticus, because plasmid uptake has only been demonstrated using conjugal transfer ([@B20]). The second targeted mutagenesis method, used in Desulfovibrio vulgaris Hildenborough, is a two-step double recombination that makes use of a nonreplicative, or suicide, vector ([@B31], [@B32]). In the first step of this method, a suicide vector, with sequences upstream and downstream of the target gene, integrates into the genome upon the first homologous recombination event ([Fig. 1B](#F1){ref-type="fig"}). Next, a second recombination event occurs whereby the vector is excised from the genome, and cells with the desired genotype are selected with an antibiotic marker and/or a counterselection marker ([@B31], [@B32]) ([Fig. 1B](#F1){ref-type="fig"}). For many bacteria, including D. magneticus, plasmid uptake and integration occur at frequencies that are too low for genetic manipulation via suicide vectors ([@B20]).

![Schematic of deletion methods used in Desulfovibrio spp. Plasmids (black lines) were designed to replace a target gene (*X*, aqua arrows) in the chromosome (blue lines) with a streptomycin resistance cassette (*strAB*, purple arrows). Regions upstream (\*) and downstream (\*\*) of the target gene (blue boxes) on the chromosome undergo recombination (red lines) with homologous regions that are cloned into the deletion plasmid. Key steps, such as recombination events (red crosses), are indicated in the boxes, and the selection steps are labeled in red. (A) Double recombination can occur in one step after plasmids are linearized (dashed lines) by endogenous restriction enzymes. Mutants are selected using the marker (e.g., *strAB*) that was exchanged with the target gene. (B) Two-step double recombination is possible when suicide vectors integrate into the chromosome in the first homologous recombination event and then recombine out after the second homologous recombination event. The first step and second step are selected for with antibiotic resistance markers (e.g., *npt*) and counterselectable markers (e.g., *sacB*), respectively. (C) A replicative deletion plasmid designed to target genes for deletion may undergo double recombination in one or two steps as shown in panels A and B, respectively. After passaging the cells without antibiotic, the mutants are selected with an antibiotic resistance cassette (e.g., *strAB*) and a counterselectable marker (e.g., *sacB*). *mob*, mobilization genes (*mobA*′, *mobB*, *mobC*); *npt*, kanamycin-resistance gene; *ori~Dm~*, origin of replication for D. magneticus; *ori~Ec~*, origin of replication for E. coli.](zam0221888360001){#F1}

Here, we describe the method we developed for targeted gene deletion using a replicative plasmid, thereby bypassing the need for suicide vector integration ([Fig. 1C](#F1){ref-type="fig"}). We generated a mutant resistant to 5-fluorouracil by making a markerless deletion of the *upp* gene, which encodes an enzyme in the pyrimidine salvage pathway that is nonessential under standard laboratory conditions. Additionally, we deleted *kupM*, a gene encoding a potassium transporter that acts as a magnetosome formation factor ([@B20]), via marker exchange with a streptomycin resistance cassette. The deletion of both *upp* and *kupM* conferred the expected phenotypes, which were subsequently complemented in *trans*. Overall, our results show that targeted mutagenesis using a replicative plasmid is possible in D. magneticus. It may also be suitable for other bacteria for which replicative plasmid uptake is possible but at a rate too low for suicide vector integration.

RESULTS {#sec2}
=======

Design of a replicative deletion plasmid using *sacB* counterselection. {#sec2-1}
-----------------------------------------------------------------------

Targeted genetic manipulation in most bacteria requires a method to efficiently deliver foreign DNA destined for integration into the chromosome. One commonly used method involves suicide vector uptake and integration prior to the first selection step ([Fig. 1B](#F1){ref-type="fig"}). In D. magneticus, plasmid transfer has only been achieved via conjugation at low efficiencies, making the uptake and subsequent integration of suicide vectors into its chromosome an unlikely event ([@B20]). As such, we attempted to bypass the use of suicide vectors and use a stable replicative plasmid designed to delete specific genes via homologous recombination ([Fig. 1C](#F1){ref-type="fig"}). Two features of this method enable the isolation of desired mutants: (i) a selectable marker is used to identify double recombination events at the targeted site and (ii) a counterselectable marker distinguishes the desired mutant cells, which have lost all remaining copies of the plasmid.

*sacB* is a common counterselection marker that is effective in many bacteria. The *sacB* gene from Bacillus subtilis encodes levansucrase, which converts sucrose to levans that are lethal to many Gram-negative bacteria, including D. vulgaris Hildenborough ([@B31], [@B33], [@B34]). To test its functionality in D. magneticus, we inserted *sacB* under the expression of the *mamA* promoter of D. magneticus (described in reference [@B20]) in a plasmid that replicates in both Escherichia coli and D. magneticus ([Fig. 2A](#F2){ref-type="fig"}). This plasmid (pAK914) and a control plasmid were then conjugated into D. magneticus. We found no growth inhibition for D. magneticus cells with the control plasmid in the presence of sucrose and kanamycin. In contrast, cells expressing *sacB* were unable to grow with kanamycin and sucrose concentrations of 1% (wt/vol) or higher (data not shown). To test if the plasmids could be cured, D. magneticus with pAK914 was passaged two times in liquid medium containing no antibiotic and plated on 1% sucrose. Individual sucrose-resistant (Suc^r^) colonies were inoculated and screened for kanamycin sensitivity (Kan^s^). All isolated colonies (*n* = 16) were Kan^s^, suggesting that the cells had lost the plasmid. These experiments demonstrate that *sacB* is a suitable counterselection marker in D. magneticus.

![Plasmids constructed for the present study. (A) Expression plasmid pAK914 expresses *sacB* from the *mamA* promoter and is the parent vector for the deletion plasmids and *upp* expression plasmid described below. (B) Replicative deletion plasmid to target *upp* for markerless deletion. The *upp* deletion cassette was cloned into XbaI-SacI of pAK914. (C) Expression plasmid used for *upp* complementation. The *upp* gene and its promoter were cloned into BamHI-SacI of pAK914. (D) Replicative deletion plasmid to target *kupM* for marker exchange mutagenesis with *strAB*. The *kupM*::*strAB* deletion cassette was cloned into XbaI of pAK914. Labeling and colors correspond to those in [Fig. 1](#F1){ref-type="fig"}.](zam0221888360002){#F2}

Construction of a Δ*upp* strain by markerless deletion. {#sec2-2}
-------------------------------------------------------

To test our replicative deletion method, we chose to target the *upp* gene, the mutation of which has a selectable phenotype. The *upp* gene encodes uracil phosphoribosyltransferase (UPRTase), a key enzyme in the pyrimidine salvage pathway that catalyzes the reaction of uracil with 5-phosphoribosyl-α-1-pyrophosphate (PRPP) to UMP and PP~i~ ([@B35]) ([Fig. 3A](#F3){ref-type="fig"}). When given the pyrimidine analog 5-fluorouracil (5-FU), UPRTase catalyzes the production of 5-fluoroxyuridine monophosphate (5-FUMP). 5-FUMP is further metabolized and incorporated into DNA, RNA, and sugar nucleotides resulting in eventual cell death ([Fig. 3A](#F3){ref-type="fig"}) ([@B36], [@B37]). Previous studies have shown that Δ*upp* mutants of D. vulgaris Hildenborough are resistant to 5-FU, while wild-type (WT) cells are effectively killed by the pyrimidine analog ([@B32], [@B38]). The D. magneticus genome has a homolog (*DMR_08390*) to the D. vulgaris Hildenborough *upp* gene that is likely functional, as detected by the sensitivity of D. magneticus to 5-FU ([Fig. 3B](#F3){ref-type="fig"} and [4A](#F4){ref-type="fig"}). To show that the *upp* gene product confers 5-FU sensitivity and to validate our replicative deletion system, we chose to target the *D. magneticus upp* gene for markerless deletion.

![(A) The *upp* gene encodes UPRTase, which is a key enzyme in the uracil salvage pathway. The product of the UPRTase reaction, UMP, is processed by downstream enzymes in pathways for RNA, DNA, and sugar nucleotide synthesis. 5-FU causes cell death by incorporating into this pathway via UPRTase. (B) Schematic of genomic regions of *upp* in the WT or the ΔMAI mutant (top) and the Δ*upp* mutant (bottom). (C) Genomic region of *kup* in WT (top) and *kup*::*strAB* (bottom) strains. Primers used to screen for the correct genotype are indicated with half arrows. (D) Δ*upp* mutants in WT and ΔMAI backgrounds were confirmed by PCR using primers P19/P20 and agarose gel electrophoresis. WT and ΔMAI strains show a band corresponding to the *upp* gene (2,691 bp), while the Δ*upp* mutants have a smaller band corresponding to a markerless deletion of the *upp* gene (2,079 bp). The lower bands are likely nonspecific PCR products. (E) *kupM*::*strAB* genotype confirmation by PCR and agarose gel electrophoresis using primers P21/P22 (WT, 3,069 bp; *kupM*::*strAB*, 3,263 bp; ΔMAI, not applicable \[NA\]).](zam0221888360003){#F3}

![*upp* mutant and complementation phenotype. Growth of the parent strain (ΔMAI) (A), *upp* deletion (ΔMAI Δ*upp*) (B), and complementation of the *upp* deletion (ΔMAI Δ*upp*/*upp^+^*) (C) when grown with 1.25 μg/ml 5-FU (○) or without 5-FU (●). Data presented are averages from 2 to 3 independent cultures; error bars indicate the standard deviations.](zam0221888360004){#F4}

To construct a *upp* deletion vector, a markerless cassette containing the regions upstream and downstream of the *upp* gene were inserted into plasmid pAK914 ([Fig. 2B](#F2){ref-type="fig"}). The resulting plasmid (pAK1126) was transferred to WT D. magneticus by conjugation and single kanamycin-resistant (Kan^r^) colonies were isolated and passaged in growth medium containing no antibiotic. Since *D*. magneticus has interesting features independent of its magnetosomes, the same deletion procedure was also carried out in a nonmagnetic strain (ΔMAI) isolated in our previous genetic studies ([@B20]). After the third passage, *upp* mutants that had lost the vector backbone were selected for with 5-FU and sucrose. Compared with those obtained using a control plasmid (pAK914), \>20-fold more 5-FU-resistant (5-FU^r^) mutants were generated using pAK1126 at a frequency of approximately 10^−6^. PCR of the region flanking the *upp* gene confirmed that the 5-FU^r^ colonies harboring pAK1126 resulted from a markerless deletion of *upp* (Δ*upp*), while 5-FU^r^ colonies harboring pAK914 were likely the result of point mutations ([Fig. 3B](#F3){ref-type="fig"} and [D](#F3){ref-type="fig"}). Similar to the results obtained for D. vulgaris Hildenborough ([@B32]), the Δ*upp* mutant of D. magneticus grew in the presence of 5-FU ([Fig. 4B](#F4){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). Complementation of the *upp* gene in *trans* restored UPRTase function, and the cells no longer grew with 5-FU ([Fig. 2C](#F2){ref-type="fig"} and [4C](#F4){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). These experiments demonstrate that a replicative plasmid can be used to directly edit the D. magneticus genome.

###### 

Growth rates and generation times of the parent strain (ΔMAI), Δ*upp* mutant, and *upp* complementation in *trans* with and without treatment with 5-FU

  Strain                 Growth rate (h^−1^)   Generation time (h)                                 
  ---------------------- --------------------- --------------------------------------- ----------- ------------
  ΔMAI                   0.077 ± 0.0017        NA[^*a*^](#T1F1){ref-type="table-fn"}   9.1 ± 0.2   NA
  ΔMAI Δ*upp*            0.079 ± 0.0017        0.070 ± 0.0040                          8.8 ± 0.2   10.0 ± 0.6
  ΔMAI Δ*upp*/*upp*^+^   0.076 ± 0.0041        NA                                      9.1 ± 0.5   NA

NA, not applicable.

Construction of a Δ*kup* strain by marker exchange mutagenesis. {#sec2-3}
---------------------------------------------------------------

Because many genetic mutations do not confer a selectable phenotype, we sought to develop our replicative deletion plasmid for marker exchange mutagenesis. To test this system, we chose to replace a gene with a known phenotype, *kupM* (*DMR_40800*), with a streptomycin-resistance gene cassette (*strAB*). *kupM* is located in the D. magneticus MAI and encodes a functional potassium transporter ([@B20]). Mutant alleles in *kupM*, including missense, nonsense, and frameshift mutations, were previously identified in our screen for nonmagnetic mutants ([@B20]). These *kupM* mutations resulted in cells that rarely contained electron-dense particles and were unable to turn in a magnetic field, as measured by the coefficient of magnetism (C~mag~) ([@B20]).

To mutate *kupM*, we inserted a marker exchange cassette, with regions upstream and downstream of *kupM* flanking *strAB*, into pAK914 ([Fig. 2D](#F2){ref-type="fig"}) to create the deletion plasmid pAK941. Following conjugation, single colonies of D. magneticus harboring pAK941 were isolated by kanamycin selection. After three passages in growth medium without selection, potential mutants were isolated at a frequency of approximately 10^−6^ on plates containing streptomycin and sucrose. Single colonies that were streptomycin resistant (Str^r^) and Suc^r^ were inoculated in liquid medium and screened for Kan^s^. Of the isolates screened (*n* = 48), 20% were Kan^s^ and 4% had the correct genotype (Δ*kupM*::*strAB*) as confirmed by PCR and sequencing ([Fig. 3C](#F3){ref-type="fig"} and [E](#F3){ref-type="fig"}).

Similar to the phenotypes previously observed in *kupM* mutants ([@B20]), Δ*kupM*::*strAB* cells were severely defective in magnetosome synthesis and turning in a magnetic field ([Fig. 5](#F5){ref-type="fig"}). Although a slight C~mag~ was measured, few cells contained electron-dense particles or magnetosomes. Importantly, the WT phenotype was rescued by expressing *kupM* from a plasmid in the Δ*kupM*::*strAB* mutant ([Fig. 5](#F5){ref-type="fig"}). These results confirm that the replicative deletion plasmid method described here can be used successfully for marker exchange mutagenesis.

![*kupM* mutant and complementation phenotype. C~mag~ values (A) and electron micrographs of WT (B), *kupM*::*strAB* (C), and Δ*kupM*::*strAB/kup^+^* (D) strains. Scale bars, 200 nm. Data presented are averages from 4 independent cultures; error bars indicate the standard deviations.](zam0221888360005){#F5}

DISCUSSION {#sec3}
==========

In this study, we expand the genetic toolbox for D. magneticus to include a replicative plasmid method for targeted mutagenesis ([Fig. 1C](#F1){ref-type="fig"}). We show the utility of this method for markerless deletion of genes with a selectable phenotype and for marker exchange mutagenesis. Some of the earliest examples of targeted mutagenesis in Gram-negative bacteria used replicative plasmids, similar to the method described here ([@B34], [@B39]). These studies, which predated the application of suicide vectors, relied on plasmid instability by introducing a second plasmid of the same incompatibility group or by limiting nutrients in the growth medium ([@B34], [@B39]).

Because the D. magneticus genetic toolbox has a limited number of plasmids, antibiotic markers, and narrow growth constraints, we used a replicative plasmid and established *sacB* as a counterselection marker to generate and isolate mutants. While *sacB* counterselection was ultimately successful, a large number of false positives were also isolated at the sucrose selection step. Mutations in *sacB* have been found to occur at a high frequency in many bacteria ([@B31], [@B40][@B41][@B43]). Indeed, we found that deletions and mutations in *P~mamA~-sacB* are abundant in the false-positive Suc^r^ Str^r^ isolates (data not shown). Alternative counterselection markers, including *upp*, have been shown to select for fewer false positives ([@B32], [@B43][@B44][@B45]). Since D. magneticus is sensitive to 5-FU only when the *upp* gene is present ([Fig. 4](#F4){ref-type="fig"}), the *upp* mutants generated in this study may be used as the parent strains for future targeted mutagenesis with *upp*, rather than *sacB*, serving as a counterselectable marker. Additionally, the combined use of *upp* and *sacB* for counterselection might reduce the false-positive background that results from the accumulation of mutations in these markers.

The replicative deletion plasmid described here was designed to replace a target gene with an antibiotic resistance marker. As such, the construction of strains with multiple directed mutations will be complicated by the need for additional antibiotic-resistance markers, which are limited in D. magneticus. These limitations may be overcome by removing the chromosomal antibiotic marker in subsequent steps ([@B34], [@B46], [@B47]). Ultimately, improvements in conjugation efficiency or methods for electroporation with high transformation efficiency are desired. Similar to the ongoing development of genetics in D. vulgaris Hildenborough, the establishment of a suicide vector delivery system in D. magneticus will enable more high-throughput targeted mutagenesis and even the construction of markerless deletion mutants ([@B26], [@B32]).

Overall, we demonstrated the utility of a replicative deletion plasmid to generate targeted mutants of D. magneticus. This method marks a crucial step in developing D. magneticus as a model for the study of anaerobic sulfate reduction and diverse mechanisms of magnetic particle formation by MTB. Both MTB and sulfate-reducing bacteria have been singled out for their role in the global cycling of numerous elements and for potential applications, such as bioremediation ([@B24], [@B25], [@B48], [@B49]). D. magneticus, in particular, may be useful in the bioremediation of heavy metals and in the global cycling of iron, since it can form both magnetosomes and other iron-containing organelles ([@B50], [@B51]). Through genetic manipulation of D. magneticus, pathways of elemental cycling and heavy-metal turnover may now be explored. Additionally, genetic manipulation of D. magneticus will further our understanding of magnetosome formation and provide answers to many longstanding questions for the deeply branching MTB. Which proteins regulate and control magnetosome formation? To what extent are lipid membranes involved in forming these crystals? How is the elongated and irregular crystal shape achieved? Finally, in addition to D. magneticus, the method described here may extend to other bacteria that are not amenable to targeted mutagenesis with suicide vectors but are able to accommodate replicative plasmids.

MATERIALS AND METHODS {#sec4}
=====================

Strains, media, and growth conditions. {#sec4-1}
--------------------------------------

The bacterial strains used in this study are listed in [Table 2](#T2){ref-type="table"}. All E. coli strains were cultured aerobically with continuous shaking at 250 rpm at 37°C in lysogeny broth (LB). D. magneticus strains were grown anaerobically at 30°C in sealed Balch tubes with a N~2~ headspace containing RS-1 growth medium (RGM) that was degassed with N~2~, unless otherwise stated ([@B51]). Sodium pyruvate (10 mM) was used as an electron donor with fumaric acid disodium (10 mM) as the terminal electron acceptor. RGM was buffered with HEPES, and the pH was adjusted to 6.7 with NaOH ([@B20]). Before inoculating with cells, RGM was supplemented with 0.8% (vol/vol) Wolfe\'s vitamins, 100 μM ferric malate, and 285 μM cysteine-HCl ([@B51]). Solid agar plates were prepared by adding 1.5% agar (wt/vol) to LB and 1% agar (wt/vol) to RGM. Vitamins (0.8% \[vol/vol\]), ferric malate (20 μM), and cysteine (285 μM), as well as antibiotics and selective agents, were added to the molten RGM agar as needed. For D. magneticus, all plating steps were carried out aerobically, and the bacteria were transferred to an anaerobic jar and incubated at 30°C for 10 to 14 days, as described previously ([@B20]). The antibiotics and selective agents used are as follows: kanamycin (50 μg/ml for E. coli strains, 125 μg/ml for D. magneticus strains), streptomycin (50 μg/ml for E. coli and D. magneticus strains), diaminopimelic acid (300 μM for E. coli WM3064), 5-FU (2.5 μg/ml for D. magneticus strains), and sucrose (1% for D. magneticus strains).

###### 

Bacterial strains and plasmids used in this study

  Strain or plasmid   Genotype or relevant characteristics                                                                                         Reference or source
  ------------------- ---------------------------------------------------------------------------------------------------------------------------- ---------------------
  Strains                                                                                                                                          
      E. coli                                                                                                                                      
          DH5α λpir   Cloning strain                                                                                                               Lab strain
          WM3064      Conjugation strain; DAP auxotroph used for plasmid transfer                                                                  Lab strain
      D. magneticus                                                                                                                                
          AK80        Nonmotile mutant of D. magneticus strain RS-1, referred to as wild type                                                      [@B51]
          AK201       ΔMAI                                                                                                                         [@B20]
          AK267       ΔMAI Δ*upp*                                                                                                                  This study
          AK268       Δ*upp*                                                                                                                       This study
          AK270       Δ*kupM*::*strAB*                                                                                                             This study
  Plasmids                                                                                                                                         
      pBMK7           Conjugative vector with pBG1 and pMB1 replicons; Kan^r^                                                                      [@B53]
      pBMC7           Conjugative vector with pBG1 and pMB1 replicons; Cm^r^                                                                       [@B53]
      pBMS6           Cloning vector; source of *strAB*; Str^r^                                                                                    [@B53]
      pLR6            pBMK7 with *P~mamA~* in HindIII-SalI; source of *P~npt~*; Kan^r^                                                             [@B20]
      pLR41           pLR6 with *P~mamA~-kupM* in SalI; Kan^r^                                                                                     [@B20]
      pAK0            Cloning vector, source of *sacB*; Kan^r^                                                                                     [@B10]
      pAK914          pLR6 with *sacB* in SalI-XbaI; Kan^r^                                                                                        This study
      pAK920          pBMC7 with *P~npt~-strAB* inserted into SacI site; Cm^r^ Str^r^                                                              This study
      pAK941          pAK914 with cassette of 1,064 bp upstream and 1,057 bp downstream of *kupM* flanking *P~npt~-strAB* in XbaI; Kan^r^ Str^r^   This study
      pAK1126         pAK914 with cassette of 991 bp upstream and 1,012 bp downstream of *upp* in XbaI-SacI; Kan^r^                                This study
      pAK1127         pAK914 with *P~upp~-upp* in BamHI-SacI; Kan^r^                                                                               This study

Plasmids and cloning. {#sec4-2}
---------------------

All plasmids used in this work are listed in [Table 2](#T2){ref-type="table"}. All cloning was performed in E. coli DH5α λpir using the Gibson method ([@B52]) or restriction enzyme ligation. For PCR amplification, KOD (EMD Millipore, Germany) and GoTaq (Promega, USA) DNA polymerases were used with the primers listed in [Table 3](#T3){ref-type="table"}. All upstream and downstream homology regions were amplified from D. magneticus genomic DNA. *strAB* and *P~npt~* were amplified from pBMS6 and pLR6, respectively, and subcloned into pBMC7 to make pAK920, which served as the template for amplifying *P~npt~-strAB* for the deletion vectors. *sacB* was amplified from pAK0 and inserted into pLR6 digested with SalI and XbaI to create pAK914. To construct a plasmid for the targeted deletion of *upp* (*DMR_08390*), 991 bp upstream and 1,012 bp downstream of *upp* were amplified and inserted into pAK914 digested with XbaI and SacI using a 3-piece Gibson assembly. To create the *upp* complementation plasmid, pAK914 was digested with BamHI and SacI, and the *upp* gene, with its promoter, was PCR amplified from D. magneticus genomic DNA. To construct pAK941 for marker exchange mutagenesis of *kupM*, a cassette of a 1,064-bp upstream region and 1,057-bp downstream region flanking *P~npt~-strAB* was assembled using Gibson cloning. The cassette was amplified and inserted into pAK914 digested with XbaI using a two-piece Gibson assembly.

###### 

Primers used in this study

  Name   Sequence from 5′ end                                 Description[^*a*^](#T3F1){ref-type="table-fn"}
  ------ ---------------------------------------------------- ------------------------------------------------
  P1     AAGCCAAGAAAAACGTCGCCAACGTCGACATGAACATCAAAAAGTTTGCA   F *sacB* for pAK914
  P2     GCTCGGTACCCGGGGATCCTCTAGAGGCCAATAGGATATCGGCATTT      R *sacB* for pAK914
  P3     CGACTCTAGAGGATCCCCGGGTACCGTAGCTTCACGCTGCCGCAAG       F *P~npt~* for pAK920
  P4     CCCGAATGTGCATGCGAAACGATCCTCATCCTGTC                  R *P~npt~* for pAK920
  P5     AGGATCGTTTCGCATGCACATTCGGGATATTTCTCTA                F *strAB* for pAK920
  P6     TAATACGACTCACTATAGGGAATTCGCCCAGGGGATAGGAGAAGTC       R *strAB* for pAK920
  P7     AAATGCCGATATCCTATTGGCCTCTAGAGAGATCGCGAAGCAGAGC       F *kupM* upstream for pAK941
  P8     TGCGGCAGCGTGAAGCTACGGTACCGCCGTAATGCGTCAGAAAGT        R *kupM* upstream for pAK941
  P9     CTTCTCCTATCCCCTGGGCGAATTCAGCCGGGTCATGGAAGTC          F *kupM* downstream for pAK941
  P10    CGAGCTCGGTACCCGGGGATCCTCTAGAGGCCAGGGAATGGAGTTT       R *kupM* downstream for pAK941
  P11    GGTACCGTAGCTTCACGCTGCCGCA                            F *P~npt~-strAB* for pAK941
  P12    GAATTCGCCCAGGGGATAGGAGAAGTCGCT                       R *P~npt~-strAB* for pAK941
  P13    GCCGATATCCTATTGGCCTCTAGAGCCTCCCAGATCGACCAGTC         F *upp* upstream for pAK1126
  P14    CTATTTGGTGCCGGATCCCATGGACGCGCTCCTGGG                 R *upp* upstream for pAK1126
  P15    AGCGCGTCCATGGGATCCGGCACCAAATAGGGGG                   F *upp* downstream for pAK1126
  P16    CGACTCACTATAGGGAATTCGAGCTCGCCAGGCAGACGGCGGTG         R *upp* downstream for pAK1126
  P17    GCCGATATCCTATTGGCCTCTAGAGAAGCTCGCCGAAAAGACC          F *P~upp~-upp* for pAK1127
  P18    CGACTCACTATAGGGAATTCGATGAAGGCGAACGAGGAAC             R *P~upp~-upp* for pAK1127
  P19    GCCCGCATTGAGGACGTG                                   To check *upp* deletion
  P20    CAGCGCCCCGAGCTTGCC                                   To check *upp* deletion
  P21    CGTCAGCAGGCAAACGG                                    To check *kupM* deletion
  P22    ACCGTTGTCTCCCATGTCTC                                 To check *kupM* deletion

F, forward; R, reverse.

*upp* and *kup* mutant generation and complementation. {#sec4-3}
------------------------------------------------------

Replicative deletion plasmids were transformed into E. coli WM3064 by heat shock and transferred to D. magneticus by conjugation, as described previously ([@B20]). Single colonies of Kan^r^ D. magneticus were isolated and inoculated in RGM containing no antibiotic. Cultures were passaged and, after the third passage, approximately 2 × 10^8^ cells were spread on 1% agar RGM plates containing either 50 μg/ml streptomycin and 1% sucrose or 2.5 μg/ml 5-FU and 1% sucrose. 5-FU^r^ Suc^r^ and Str^r^ Suc^r^ colonies harboring plasmids pAK1126 and pAK941, respectively, were recovered at a frequency of approximately 10^−6^. Single colonies were screened for Kan^s^ and by PCR using the primers listed in [Table 3](#T3){ref-type="table"}. Successful *upp* and *kup* mutants were confirmed by Sanger sequencing. The expression plasmids for the complementation of Δ*kup*::*strAB* and Δ*upp*, as well as empty vectors for controls, were transferred to D. magneticus strains as described above. Transconjugants were inoculated in RGM containing kanamycin to maintain the plasmids.

Mutant phenotype and complementation analyses. {#sec4-4}
----------------------------------------------

The growth and coefficient of magnetism (C~mag~) of D. magneticus strains were measured in a Spec20 spectrophotometer at an optical density of 650 nm (OD~650~), as described previously ([@B10], [@B51]). For *upp* mutant and complementation analyses, RGM was supplemented with 5-FU (1.25 μg/ml in 0.01% dimethyl sulfoxide \[DMSO\]) or DMSO (0.01%), and the growth was measured for WT and Δ*upp* strains with an empty vector (pAK914) and for the Δ*upp* strain with the complementation plasmid pAK1127. For *kup* mutant and complementation analyses, the C~mag~ was measured by placing a large bar magnet parallel or perpendicular to the sample to measure the maximum or minimum absorbance, respectively, as the D. magneticus strains rotate 90° with the magnetic field. The ratio of maximum to minimum absorbances was calculated as the C~mag~ ([@B10]). Whole-cell transmission electron microscopy (TEM) was performed as previously described ([@B51]). The C~mag~ calculations and TEM were performed for WT D. magneticus with an empty vector (pBMK7) and the Δ*kup*::*strAB* strain with an empty vector (pBMK7) or complementation plasmid (pLR41). For all growth measurements, C~mag~ measurements, and TEM, the cells harboring the plasmids were maintained with 125 μg/ml kanamycin.
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